This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Panacea Biotech Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations of Sampath Kumar Devarajan
Introduction
Sampath Kumar Devarajan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release compositions. His work focuses on improving the efficacy and safety of medications, which is crucial for patient care.
Latest Patents
Sampath Kumar Devarajan holds a patent for "Extended release compositions comprising mycophenolate sodium and processes thereof." This invention provides extended release pharmaceutical compositions that utilize mycophenolate sodium as the active agent. The compositions are designed to exhibit a characteristic release profile during in-vitro dissolution studies. They ensure that mycophenolate sodium is released in a sustained manner in-vivo, thereby reducing the chances of gastrointestinal side effects while maintaining the bioavailability of the active agent. The invention also outlines processes for preparing dosage form compositions and methods for their therapeutic use, particularly in managing immunosuppressant indicated diseases.
Career Highlights
Sampath Kumar Devarajan is associated with Panacea Biotech Limited, where he continues to innovate in the pharmaceutical sector. His work is instrumental in developing new therapeutic solutions that address critical health issues.
Collaborations
He collaborates with talented professionals in his field, including Rajesh Jain and Sukhjeet Singh. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Sampath Kumar Devarajan's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving patient outcomes. His work exemplifies the importance of research and development in creating effective medical solutions.